Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2013-5582

2. Registrant Information.

Registrant Reference Number: 1-35037393

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.


5. Location of incident.


Prov / State: VIRGINIA

6. Date incident was first observed.


Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.


PMRA Registration No.       PMRA Submission No.       EPA Registration No. 2596-78

Product Name: UltraGuard Flea/Tick Powder for Cats

  • Active Ingredient(s)
      • Guarantee/concentration 3.3 %

7. b) Type of formulation.


Application Information

8. Product was applied?


9. Application Rate.


10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?


Subform III: Domestic Animal Incident Report

1. Source of Report

Medical Professional

2. Type of animal affected

Cat / Chat

3. Breed


4. Number of animals affected


5. Sex


6. Age (provide a range if necessary )


7. Weight (provide a range if necessary )



8. Route(s) of exposure


9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

>24 hrs <=3 days / >24 h <=3 jours

11. List all symptoms


  • Respiratory System
    • Symptom - Rapid breathing
  • General
    • Symptom - Death
    • Symptom - Hypothermia
    • Symptom - Weakness
    • Symptom - Lethargy
  • Gastrointestinal System
    • Symptom - Diarrhea
  • Nervous and Muscular Systems
    • Symptom - Difficulty walking

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.


14. a) Was the animal hospitalized?


14. b) How long was the animal hospitalized?

15. Outcome of the incident


16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1-35037393 - The reporter, a veterinarian, indicated that two cats were exposed to an insecticidal powder containing the active ingredient tetrachlorvinphos. The pet owner applied the product to one of their 8-week-old cats (Subform III #1) two days prior to initial contact with the registrant. One day later the cat started to develop symptoms which progressively worsened over the next two days. The reporter also indicated that there was a second 8-week-old cat in the house that may have been exposed to the product through contact with the first cat. The pet owner brought both cats to the clinic two days after the product had been applied. The cat that had the product applied directly to it (Subform III #1) presented limp, weak with rapid shallow breathing, and hypothermic. The other cat was also weak with shallow rapid breathing and hypothermic. Per the reporter, neither cat presented with the classic organophosphate muscarinic symptoms. Both cats were bathed on presentation and treated with a dose of atropine but the cat that had the product applied directly to it passed away soon after the first dose of atropine was given. The reporter indicated that the other cat had not responded to his high dose of atropine (0.1 mg/kg). The reporter was advised that per package labeling the product is not meant to be applied to animals who are less than 12 weeks of age. The reporter was further advised that the symptoms and the lack of response to atropine likely indicate that the cats illness is not related to product exposure and additional diagnostics were recommended. On follow-up call, one day later, the reporter indicated that he did not think that the living cats symptoms were from the product and he was not treating the cat for possible pneumonia. No further information is available.

To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification


19. Provide supplemental information here